Next Article in Journal
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
Next Article in Special Issue
Treatment of Post-Traumatic Stress Disorder Nightmares at a Veterans Affairs Medical Center
Previous Article in Journal / Special Issue
Posttraumatic Stress Disorder: Overview of Evidence-Based Assessment and Treatment
 
 
Article

Article Versions Notes

J. Clin. Med. 2016, 5(11), 106; https://doi.org/10.3390/jcm5110106
Action Date Notes Link
article pdf uploaded. 23 November 2016 09:15 CET Version of Record https://www.mdpi.com/2077-0383/5/11/106/pdf
article xml uploaded. 23 November 2016 09:15 CET Original file https://www.mdpi.com/2077-0383/5/11/106/xml
article html file updated 23 November 2016 09:16 CET Original file -
article html file updated 30 November 2016 05:02 CET Update -
article html file updated 4 May 2019 21:40 CEST Update -
article html file updated 22 September 2019 06:29 CEST Update -
article html file updated 7 February 2020 18:27 CET Update https://www.mdpi.com/2077-0383/5/11/106/html
Back to TopTop